These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6652914)

  • 21. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C9 is inserted into membranes in a globular conformation.
    Marazziti D; Luzio JP; Stanley KK
    FEBS Lett; 1989 Jan; 243(2):347-50. PubMed ID: 2917655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement factor 9 deficiency in serum of human neonates.
    Lassiter HA; Watson SW; Seifring ML; Tanner JE
    J Infect Dis; 1992 Jul; 166(1):53-7. PubMed ID: 1607708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melittin antibodies.
    Laine RO; Esser AF
    J Immunol; 1989 Jul; 143(2):553-7. PubMed ID: 2472443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex.
    Bhakdi S; Tranum-Jensen J
    Biochem J; 1983 Mar; 209(3):753-61. PubMed ID: 6870789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human complement C7 and C9 in fetal and newborn sera.
    Adinolfi M; Beck SE
    Arch Dis Child; 1975 Jul; 50(7):562-4. PubMed ID: 1172656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
    Nishizaki M
    Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.
    Orren A; O'Hara AM; Morgan BP; Moran AP; Würzner R
    Immunology; 2003 Mar; 108(3):384-90. PubMed ID: 12603605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A; Moriyama T; Inoue K; Inai S
    J Immunol; 1988 Apr; 140(7):2317-21. PubMed ID: 3351301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants.
    Schultz SJ; Aly H; Hasanen BM; Khashaba MT; Lear SC; Bendon RW; Gordon LE; Feldhoff PW; Lassiter HA
    Neurosci Lett; 2005 Apr; 378(1):1-6. PubMed ID: 15763162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives.
    Schumacher M; Nanninga A; Delfs T; Mukhopadhyay AK; Leidenberger FA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):617-23. PubMed ID: 1639960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
    Dalmasso AP; Benson BA; Falk RJ
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolism of C9 in normal subjects and in patients with autoimmune disease.
    Greenstein JD; Peake PW; Charlesworth JA
    Clin Exp Immunol; 1996 Apr; 104(1):160-6. PubMed ID: 8603521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
    Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
    Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.
    Würzner R; Xu H; Franzke A; Schulze M; Peters JH; Götze O
    Immunology; 1991 Sep; 74(1):132-8. PubMed ID: 1718850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of complement components C5 and C9 and decreased antitrypsin activity in the serum of patients with X-linked vacuolated myopathy.
    Louboutin JP; Villanova M; Ulrich G; De Clerck LS; Fardeau M; Sagniez M
    Muscle Nerve; 1996 Sep; 19(9):1144-7. PubMed ID: 8761271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of complement C4 and C9 genes by human astrocytes.
    Walker DG; Kim SU; McGeer PL
    Brain Res; 1998 Oct; 809(1):31-8. PubMed ID: 9795119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.